Show simple item record

dc.contributor.authorMakael Bohtera, F.M.
dc.contributor.authorPatro, M.
dc.date.accessioned2014-06-17T10:23:24Z
dc.date.available2014-06-17T10:23:24Z
dc.date.issued2013EN
dc.identifier.issn1020-3397EN
dc.identifier.otherEN
dc.identifier.urihttp://www.who.int/iris/handle/10665/118609
dc.description1-7EN
dc.description.abstractSurgery is the mainstay of treatment for hydatid cyst, but the development of antihelminths has become a boon in the management of the disease. The role of medical management is now well defined, alone or with surgery or percutaneous aspiration, injection and re-aspiration [‎PAIR]‎. The aim of this study was to evaluate the effect of antihelminth treatment on 16 selected patients [‎10 females and 6 males]‎ with hydatid cyst. Hydatid cyst was diagnosed radiologically and treated with albendazole. Patients were followed up for 12 months after completion of therapy. Hydatid cyst collapsed completely in 10 patients; recurrence of cyst during the observation period was recorded in 2 patients. No patient in this study developed side-effects from the treatment. We suggest that albendazole is a safe and effective agent for uncomplicated hydatid cyst and should be advised for any hydatid cyst < 5 cm or for surgically inaccessible hydatid cystEN
dc.language.isoenEN
dc.titleMedical management of abdominal hydatid cyst in a teaching hospital in Eastern Libya: treatment and outcome in 16 cases, 2004-2010EN
dc.relation.ispartofjournalEMHJ - Eastern Mediterranean Health Journal, 19 (‎Supp.2)‎, 1-7, 2013


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(‎s)‎

Show simple item record